Open Access
Subscription Access
Understanding Anti-Anxiety Medications, Muscle Relaxants and Sedative-Hypnotics in Dentistry
Abstract
Dental anxiety is a general issue that influence many people. Often preventing them from seeking necessary dental care. To reduce this anxiety and ensure a comfortable experience, dentists may employ various medications. Among these are anti_ anxiety medications, core muscle relaxants and sedative_ hypnotics. Understanding these medications and their riles in dentistry is critical for both patients and dental professionals. Since benzodiazepines have relaxing properties, they are frequently utilized in dentistry. These drugs work by enhancing the effects of GABA, or gamma-aminobutyric acid a neurotransmitter that decreases brain activity. This results in feelings of relaxation as well as sedation. Examples of benzodiazepines used in dentistry include diazepam ( valium ) and lirazepam ( Ativan). They are administered in a typical manner orally before a dental procedure to help patients feel more at ease. Core muscle relaxants are frequently used in dentistry to reduce muscle tension and decrease discomfort especially during Procedures. These medications target skeletal muscles, assisting to relax them and facilitate dental work. By enhancing muscle relaxation, these medications can help in achieving better outcomes and patient comfort especially during dental treatments. Sedative_ hypnotics are frequently used in conjunction with local anesthetics to provide a mire comfortable and stress_ free experience fir patients undergoing dental procedures. The use of these medications in dentistry serves many purposes and these purposes include anxiety reduction, improved patient experience, muscle relaxants and sedation. Finally it is concluded that anti_ anxiety medications, muscle relaxants and sedative_ hypnotic play valuable roles in dentistry, assisting to reduce anxiety, decrease muscle tension and increase relaxation particularly during dental procedures.
References
Wang, Y. C., Lin, I. H., Huang, C. H., & Fan, S. Z. (2012). Dental anesthesia for patients with special needs. Acta Anaesthesiologica Taiwanica, 50(3), 122-125.
Abbas, B., Maqsood, A., Rahat Geelani, S. R., Sattar, M., Rahim, M., & Khurshid, Z. (2022). Estimating the need for sedation in patients with dental anxiety and medical complexities reporting to tertiary care dental hospital using the IOSN tool. International Journal of Dentistry, 2022.
Goodchild, J. H., & Donaldson, M. (2011). The use of sedation in the dental outpatient setting: a web-based survey of dentists. Dent Implantol Update, 22(11), 73-80.
Coke, J. M., & Edwards, M. D. (2009). Minimal and moderate oral sedation in the adult special needs patient. Dental Clinics of North America, 53(2), 221-230.
Oznurhan, F., & Derdiyok, C. (2020). The drugs and application methods in dental sedation. Dent Res Pract, 4(1), 1-6.
Capp, P. L., De Faria, M. E., Siqueira, S. R., Cillo, M. T., Prado, E. G., & De Siqueira, J. T. (2010). Special care dentistry: Midazolam conscious sedation for patients with neurological diseases. European journal of paediatric dentistry, 11(4), 162-164.
Dos Santos, B. M., Silva-Júnior, G. O., Marinho, M. A., Papa, E. G., & Bastos, L. F. (2019). Contribution of benzodiazepines in dental care of patients with special needs. Journal of clinical and experimental dentistry, 11(12), e1170.
Working Group on Guidelines Development for Intravenous Sedation in Dentistry, the Japanese Dental Society of Anesthesiology. (2018). Practice Guidelines for Intravenous Conscious Sedation in Dentistry (2017) Developed By The Japanese Dental Society of Anesthesiology for Dentists Practicing Sedation in Japan. Anesthesia Progress, 65(4), e1-e18.
Griffin, C. E., Kaye, A. M., Bueno, F. R., & Kaye, A. D. (2013). Benzodiazepine pharmacology and central nervous system–mediated effects. Ochsner Journal, 13(2), 214-223.
Kilbaugh, T. J., Friess, S. H., Raghupathi, R., & Huh, J. W. (2010). Sedation and analgesia in children with developmental disabilities and neurologic disorders. International journal of pediatrics, 2010.
Weissheimert, T., da Silveira Gerzson, A., Schwengber, H.E., Neto, A.M. (2016). Benzodiazepines for conscious sedation in the dental office. Stomatos, 22(42) 42-53
Prommer, E. (2020). Midazolam: an essential palliative care drug. Palliative care and social practice, 14, 2632352419895527.
Suri, Y. (2000). Evaluation of midazolam and diazepam for pre-operative sedation. Medical Journal Armed Forces India, 56(4), 287-292.
Mancuso, C. E., Tanzi, M. G., & Gabay, M. (2004). Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 24(9), 1177-1185.
Goudra, B. G., & Singh, P. M. (2014). Remimazolam: the future of its sedative potential. Saudi Journal of Anaesthesia, 8(3), 388-391.
Kim, K. M. (2022). Remimazolam: pharmacological characteristics and clinical applications in anesthesiology. Anesthesia and Pain Medicine, 17(1), 1.
Xiao-hua, T. I. A. N., Yan-zhong, Y. A. N. G., & Xiao-feng, L. I. (2015). Evaluation of N2O inhalation and oral midazolam conscious sedation in pediatric dentistry of children with intellectual disability. Shanghai Journal of Stomatology, 24(3), 370.
Hosey, M. T., & UK National Clinical Guidelines in Pediatric Dentistry. (2002). Managing anxious children: the use of conscious sedation in paediatric dentistry. International journal of Paediatric dentistry, 12(5), 359-372.
Krajewski, W., Kucharska, M., Wesolowski, W., Stetkiewicz, J., & Wronska-Nofer, T. (2007). Occupational exposure to nitrous oxide–the role of scavenging and ventilation systems in reducing the exposure level in operating rooms. International journal of hygiene and environmental health, 210(2), 133-138.
Refbacks
- There are currently no refbacks.